Clinical trial
Tumor Cell and DNA Detection in the Peripheral Blood of Patients With Hematological Malignancy
NCT04841447 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tumor Cell and DNA Detection in the Peripheral Blood of Patients With Hematological Malignancy
- Lead sponsor
- University of Missouri-Columbia
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 20, 2020
- Completion date
- March 20, 2027
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hematological malignancy